Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant SOX Chemotherapy Followed by Surgery in Clinical Stage III Gastric Cancer
jRCTs051180020Phase 2Completed
- Start
- Jun 2016
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tegafur and oxaliplatin in gastric adenocarcinoma. Primary endpoint: Percent completion of the protocol treatment. Started Jun 2016; status: completed.
02
Drugs
tegafuroxaliplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on jRCTs051180020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180020.